General Info

Isis Pharmaceuticals is a biopharmaceutical company that researches and develops therapeutic drugs for conditions, including inflammatory, metabolic, and cardiovascular diseases, and cancer. Founded in 1989, Isis owns more than 1,500 issued patents worldwide, and discovers and develops ribonucleic acid-based drugs. Its drug discovery and development division provides antisense inhibitors from its RNA-based technology. Its IBIS T5000 biosensor system is capable of identifying infectious organisms and is used by government agencies in biowarfare defense, epidemiological surveillance and forensics. The biosensor system is also used in pharmaceutical process control, hospital-associated infection control, and infectious disease diagnostics. Isis Pharmaceuticals is headquartered in Carlsbad, Calif.